Point72 Hong Kong’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,595
| Closed | -$177K | – | 1878 |
|
|
2022
Q3 | $177K | Buy |
+2,595
| New | +$143K | 0.01% | 1083 |
|
|
2022
Q1 | – | Sell |
-4,202
| Closed | -$123K | – | 2495 |
|
|
2021
Q4 | $123K | Sell |
4,202
-1,250
| -23% | -$38.7K | ﹤0.01% | 1134 |
|
|
2021
Q3 | $139K | Sell |
5,452
-25,821
| -83% | -$759K | ﹤0.01% | 1263 |
|
|
2021
Q2 | $1.09M | Buy |
31,273
+25,130
| +409% | +$981K | 0.04% | 680 |
|
|
2021
Q1 | $250K | Buy |
+6,143
| New | +$282K | 0.01% | 999 |
|
|
2020
Q2 | – | Sell |
-367
| Closed | -$19K | – | 1507 |
|
|
2020
Q1 | $19K | Sell |
367
-6
| -2% | -$402 | 0.01% | 573 |
|
|
2019
Q4 | $30K | Buy |
373
+362
| +3,291% | +$21.5K | 0.01% | 805 |
|
|
2019
Q3 | $1K | Buy |
+11
| New | +$573 | ﹤0.01% | 934 |
|
|
2018
Q4 | – | Sell |
-20
| Closed | -$1K | – | 1293 |
|
|
2018
Q3 | $1K | Sell |
20
-1,951
| -99% | -$86.4K | ﹤0.01% | 836 |
|
|
2018
Q2 | $89K | Buy |
+1,971
| New | +$89.7K | 0.03% | 328 |
|
|
2017
Q4 | – | Sell |
-615
| Closed | -$19K | – | 1163 |
|
|
2017
Q3 | $19K | Sell |
615
-938
| -60% | -$26.4K | 0.01% | 402 |
|
|
2017
Q2 | $42K | Buy |
+1,553
| New | +$46.2K | 0.04% | 251 |
|
Other funds holding GBT
Point72 Hong Kong's GBT Position: Q4 2022 in Review
Point72 Hong Kong sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 2,595 shares — an estimated $177K sold.
Point72 Hong Kong first reported a position in GBT in Q2 2017 and held it in 12 quarters. The position peaked at $1.09M in Q2 2021. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Point72 Hong Kong reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Point72 Hong Kong sold 2,595 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $177K.
- Point72 Hong Kong first reported a position in Global Blood Therapeutics, Inc. in Q2 2017 and held it in 12 quarters.
- Point72 Hong Kong's Global Blood Therapeutics, Inc. position peaked at $1.09M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.